Carrie D'Andrea
Director Técnico/Científico/I+D en ACASTI PHARMA INC. .
Fortuna: - $ al 30/04/2024
Cargos activos de Carrie D'Andrea
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ACASTI PHARMA INC. | Director Técnico/Científico/I+D | 08/05/2023 | - |
Historial de carrera de Carrie D'Andrea
Antiguos cargos conocidos de Carrie D'Andrea.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 01/10/2020 | 01/04/2021 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Director Técnico/Científico/I+D | 01/10/2014 | 01/03/2019 |
Formación de Carrie D'Andrea.
Temple University (Pennsylvania) | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Italia | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Bolsa de valores
- Insiders
- Carrie D'Andrea
- Experiencia